HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Proximal myopathy caused by latrogenic phosphate depletion.

Abstract
Severe proximal myopathy associated with hypophosphatemia developed in three patients with chronic renal failure who had been treated with aluminum hydroxide gel. The syndrome was characterized by severe pain, muscular stiffness, and weakness. The illness was originally misdiagnosed both as uremic myopathy and as an exacerbation of rheumatoid arthritis. In one patient, the correct diagnosis was made when symptomatic relief corresponded to the rise of serum phosphate levels. Discontinuation of antacid therapy was followed by gradual recovery. Oral sodium phosphate brought prompt alleviation of muscular pain and stiffness.
AuthorsM Ravid, M Robson
JournalJAMA (JAMA) Vol. 236 Issue 12 Pg. 1380-1 (Sep 20 1976) ISSN: 0098-7484 [Print] United States
PMID989096 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Phosphates
  • Aluminum Hydroxide
Topics
  • Adult
  • Aluminum Hydroxide (adverse effects, therapeutic use)
  • Female
  • Humans
  • Hyperparathyroidism, Secondary (prevention & control)
  • Iatrogenic Disease
  • Kidney Failure, Chronic (drug therapy)
  • Male
  • Middle Aged
  • Muscular Diseases (etiology)
  • Phosphates (deficiency)
  • Pruritus (prevention & control)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: